Ruvie Martin

3.7k citations
29 papers · 2.1k indexed · 1 hit paper · h-index 15
Topics
Spondyloarthritis Studies and Treatments (14 papers)Psoriasis: Treatment and Pathogenesis (11 papers)Autoimmune and Inflammatory Disorders Research (11 papers)

In The Last Decade

Ruvie Martin

27 papers receiving 2.1k citations

Hit Papers

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing ...20152026201820222015200400600

Peers

Ruvie Martin
Comparison fields: 5 of 89
  • Rheumatology 1.3k
  • Immunology 1.0k
  • Hematology 579
  • Neurology 335
  • Pulmonary and Respiratory Medicine 285
Replace H. Michael Belmont with:
H. Michael Belmont United States
J Rovenský Slovakia
Pál Soltész Hungary
Mauro Galeazzi Italy
Alberta Hoi Australia
Antonis Fanouriakis Greece
Won Park South Korea
C. Gaich United States
Nemanja Damjanov Serbia
K. Thiele Germany
Ruvie Martin relative to H. Michael Belmont United States H. Michael Belmont's profile →
Citations per field
00.5×2.7×
H. Michael Belmont · 1×
Citations per year

Countries citing papers authored by Ruvie Martin

Since Specialization
Citations

This map shows the geographic impact of Ruvie Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruvie Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruvie Martin more than expected).

Fields of papers citing papers by Ruvie Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruvie Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruvie Martin. The network helps show where Ruvie Martin may publish in the future.

Co-authorship network of co-authors of Ruvie Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Ruvie Martin. A scholar is included among the top collaborators of Ruvie Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruvie Martin. Ruvie Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 2
5 5
6 3
7 6
8 2
9 3
10 179
11 33
12 19
13 24
14 83
15 188
16 64
17
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitisbreakdown →
732
18 312
19 66
20 3

About Ruvie Martin

Ruvie Martin is a scholar working on Rheumatology, Hematology and Immunology, having authored 29 papers that have together received 2.1k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (14 papers), Psoriasis: Treatment and Pathogenesis (11 papers) and Autoimmune and Inflammatory Disorders Research (11 papers). The work is most often cited by research in Rheumatology (1.3k citations), Hematology (579 citations) and Immunology (1.0k citations). Ruvie Martin has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Hanno B. Richards, Shephard Mpofu, Brian Porter, Dominique Baeten, Xenofon Baraliakos, Joachim Sieper, Jürgen Braun, Paul Emery, Atul Deodhar and Maxime Dougados. Their work appears in journals such as New England Journal of Medicine, The Lancet and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026